MarketMoodz
Morgan Stanley Flags 15%+ Dividend Cuts in REITs and Chemicals
Morgan Stanley’s screen identified companies that trimmed dividends by at least 15% over the past 12 months, naming Dow Inc. and Healthcare Realty Trust among the affected REIT and chemical names. For income-focused investors, those cuts shrink predictable cash flow and signal issuers are prioritizing balance-sheet repair amid a higher-for-longer rate backdrop.
Key Takeaways
- Morgan Stanley flagged firms that cut payouts by 15% or more in the past year, including Dow Inc. (cut to $0.35 quarterly) and Healthcare Realty Trust (cut to $0.24 quarterly).
- Dow’s dividend now yields about 4.2% and Healthcare Realty’s about 4.7%, even after the cuts, keeping them visible to income seekers.
- Other names on Morgan Stanley’s screen include LyondellBasell, DuPont, Baxter International and Alexandria Real Estate Equities, though the full list and methodology weren’t published.
- Morgan Stanley notes shares often fall in the first six months after a cut but can recover as firms reduce refinancing risk and strengthen balance sheets.
- Income portfolios should reassess payout sustainability, diversify across resilient sources, and consider hedging or rebalancing rather than chasing yield alone.
People Involved
- No specific individuals mentioned
Entities Involved
- Morgan StanleyResearch provider conducting the dividend-cut screen
- Dow Inc. (DOW)Chemical maker; cut quarterly dividend to $0.35 last July; cited yield ~4.2%
- Healthcare Realty Trust (HR)Real estate investment trust; cut quarterly dividend to $0.24 last July; cited yield ~4.7%
- LyondellBasell Industries (LYB)Chemical/materials company listed on Morgan Stanley's screen
- DuPont (DD)Materials/chemical company listed on Morgan Stanley's screen
- Baxter International (BAX)Healthcare/medical products company listed on Morgan Stanley's screen
- Alexandria Real Estate Equities (ARE)REIT focused on life-science real estate listed on Morgan Stanley's screen
MarketMoodz Analysis
Dividend cuts of 15% or more force a re-evaluation of income allocations. Even though Dow and Healthcare Realty still yield roughly 4%–4.7% after their July reductions, the reliability of those payouts has changed: companies are trading yield for liquidity. That trade-off can make shares volatile in the near term as investors price in refinancing risk and the likelihood of future cuts, especially for sectors with heavy balance-sheet needs like chemicals and some REITs.
Morgan Stanley’s framework—documenting an initial negative price reaction followed by potential recovery as balance sheets repair—matches past dividend-cut cycles where firms prioritized reducing leverage and preserving cash for higher-return investments. For investors this means a binary outcome: disciplined issuers that use cash prudently can regain investor confidence and reward holders over time, while those that fail to stabilize cash flow risk prolonged underperformance. The note that nine of 20 analysts rate Dow a buy or strong buy (per LSEG) underlines how the market is split between valuation optimism and income risk.
What to watch next: quarterly results and refinancing schedules, analyst revisions, and macro prints that govern borrowing costs. The report and figures cited are time-sensitive and based on CNBC’s coverage of Morgan Stanley’s screen, so verify yields, recent price moves and the full list before trading. For retirees and income managers, the practical steps are clear—stress-test payout assumptions, diversify income sources, and avoid chasing headline yields without checking balance-sheet improvements.
Source: Original Article